Praxis shareholders back directors, auditor and pay
Praxis Precision Medicines, Inc. reported results of its 2026 Annual Meeting of Stockholders held on June 10, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
Praxis Precision Medicines, Inc. reported results of its 2026 Annual Meeting of Stockholders held on June 10, 2026. Stockholders elected three Class III directors — Gregory Norden, Marcio Souza and William Young — to serve until the 2029 annual meeting, with each receiving more than 21 million votes in favor.
Stockholders also ratified Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 26,667,376 votes for and limited opposition. In an advisory, non-binding vote, stockholders approved the compensation of the company’s named executive officers, with 24,054,017 votes for and 824,318 against. No other matters were submitted for a vote.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Votes for Gregory Norden: 24,597,327 votes
Votes for Marcio Souza: 24,771,396 votes
Votes for William Young: 21,293,535 votes
+3 more
6 metrics
Votes for Gregory Norden
24,597,327 votes
Election as Class III director at 2026 annual meeting
Votes for Marcio Souza
24,771,396 votes
Election as Class III director at 2026 annual meeting
Votes for William Young
21,293,535 votes
Election as Class III director at 2026 annual meeting
Auditor ratification votes for
26,667,376 votes
Ernst & Young LLP as auditor for year ending Dec. 31, 2026
Say-on-pay votes for
24,054,017 votes
Advisory approval of named executive officer compensation
Broker non-votes on director elections
1,815,967 votes
Applies to each Class III director nominee
Key Terms
broker non-vote, independent registered public accounting firm, advisory (non-binding) basis, Annual Meeting of Stockholders, +1 more
5 terms
broker non-vote financial
"Class III Director Nominees | Votes For | Votes Withheld | Broker Non-Vote"
A broker non-vote happens when a brokerage firm holds shares in street name for a client but does not cast a ballot on a particular shareholder item because the broker lacks discretionary authority to vote that matter. Think of it like a person who owns a ticket but the ticket-holder refuses to vote on some issues; the share counts for ownership but not for that vote, which can affect whether proposals reach the required number of votes or a quorum.
independent registered public accounting firm financial
"ratification of Ernst & Young LLP as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
advisory (non-binding) basis financial
"approved, on an advisory (non-binding) basis, the compensation of the Company’s named executive officers"
Annual Meeting of Stockholders financial
"held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”), at which a quorum was present"
quorum financial
"held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”), at which a quorum was present"
A quorum is the minimum number of members needed to officially hold a meeting or make decisions. It ensures that decisions are made with enough participation to represent the group’s interests, much like a majority must be present for a vote to be valid. For investors, understanding quorum is important because it affects when and how important company or organization decisions can be legally made.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Praxis Precision Medicines (PRAX) stockholders vote on at the 2026 annual meeting?
Stockholders voted on three items: electing three Class III directors, ratifying Ernst & Young LLP as independent auditor for 2026, and approving, on an advisory basis, compensation for named executive officers. All three proposals received majority support based on the reported vote totals.
Were the director nominees elected at the Praxis Precision Medicines (PRAX) 2026 annual meeting?
Yes, all three Class III director nominees were elected. Gregory Norden, Marcio Souza, and William Young each received a majority of votes cast in favor and will serve until the 2029 annual meeting or until earlier death, resignation, or removal, consistent with the company’s governance framework.
How did Praxis Precision Medicines (PRAX) stockholders vote on the 2026 auditor ratification proposal?
Stockholders ratified Ernst & Young LLP as independent registered public accounting firm for the year ending December 31, 2026. The vote totals were 26,667,376 for, 39,285 against, and 17,570 abstentions, with no broker non-votes reported for this ratification item in the results.
What were the results of the Praxis Precision Medicines (PRAX) say-on-pay advisory vote in 2026?
Stockholders approved, on a non-binding advisory basis, the compensation of named executive officers. The vote totals were 24,054,017 for, 824,318 against, and 29,929 abstentions, along with 1,815,967 broker non-votes, indicating majority support for the company’s executive pay program as presented.
Were any other matters voted on at the Praxis Precision Medicines (PRAX) 2026 annual meeting?
No, only three proposals were submitted: election of Class III directors, auditor ratification, and an advisory vote on executive compensation. The company stated explicitly that no other matters were submitted to, or voted on by, stockholders at the 2026 annual meeting.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates